Literature DB >> 24958097

The vanishing role of whole brain radiotherapy for primary central nervous system lymphoma.

Michael Weller1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24958097      PMCID： PMC4096183          DOI： 10.1093/neuonc/nou120

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  15 in total

1.  NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.

Authors:  Ulrich Herrlinger; Wilhelm Küker; Martin Uhl; Hans-Peter Blaicher; Hans-Otto Karnath; Lothar Kanz; Michael Bamberg; Michael Weller
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

2.  High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Authors:  Eckhard Thiel; Agnieszka Korfel; Peter Martus; Lothar Kanz; Frank Griesinger; Michael Rauch; Alexander Röth; Bernd Hertenstein; Theda von Toll; Thomas Hundsberger; Hans-Günther Mergenthaler; Malte Leithäuser; Tobias Birnbaum; Lars Fischer; Kristoph Jahnke; Ulrich Herrlinger; Ludwig Plasswilm; Thomas Nägele; Torsten Pietsch; Michael Bamberg; Michael Weller
Journal:  Lancet Oncol       Date:  2010-10-20       Impact factor: 41.316

3.  Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.

Authors:  D F Nelson; K L Martz; H Bonner; J S Nelson; J Newall; H D Kerman; J W Thomson; K J Murray
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

Review 4.  Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

Authors:  M Reni; A J Ferreri; N Guha-Thakurta; J Y Blay; S Dell'Oro; P Biron; F H Hochberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

5.  Long-term survival in primary CNS lymphoma.

Authors:  L E Abrey; L M DeAngelis; J Yahalom
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

6.  Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.

Authors:  Hendrik Pels; Ingo G H Schmidt-Wolf; Axel Glasmacher; Holger Schulz; Andreas Engert; Volker Diehl; Anton Zellner; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Marlies Vogt-Schaden; Gerlinde Egerer; Udo Bode; Carlo Schaller; Martina Deckert; Rolf Fimmers; Christoph Helmstaedter; Aslihan Atasoy; Thomas Klockgether; Uwe Schlegel
Journal:  J Clin Oncol       Date:  2003-11-03       Impact factor: 44.544

7.  Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

Authors:  K Hoang-Xuan; L Taillandier; O Chinot; P Soubeyran; U Bogdhan; J Hildebrand; M Frenay; N De Beule; J Y Delattre; B Baron
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

8.  Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

Authors:  Gaurav D Shah; Joachim Yahalom; Denise D Correa; Rose K Lai; Jeffrey J Raizer; David Schiff; Renato LaRocca; Barbara Grant; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

9.  Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

Authors:  James L Rubenstein; Eric D Hsi; Jeffrey L Johnson; Sin-Ho Jung; Megan O Nakashima; Barbara Grant; Bruce D Cheson; Lawrence D Kaplan
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544

10.  Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.

Authors:  Andreas F Hottinger; Lisa M DeAngelis; Joachim Yahalom; Lauren E Abrey
Journal:  Neurology       Date:  2007-09-11       Impact factor: 9.910
View more
  3 in total

1.  The Impact of Early Corticosteroid Pretreatment Before Initiation of Chemotherapy in Patients With Primary Central Nervous System Lymphoma.

Authors:  Florian Gessler; Joshua D Bernstock; Bedjan Behmanesh; Uta Brunnberg; Patrick Harter; Daniel Ye; Gregory K Friedman; Martin-Leo Hansmann; Marlies Wagner; Volker Seifert; Lutz Weise; Gerhard Marquardt
Journal:  Neurosurgery       Date:  2019-08-01       Impact factor: 4.654

Review 2.  Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review.

Authors:  Gaurav Nepal; Mahika Khurana; Domenica Herrera Bucheli; Siddhartha Bhandari; Utsav Joshi; Riwaj Bhagat; Jessica Holly Rehrig; Prasun Pudasainee; Yow Ka Shing; Juan Fernando Ortiz; Rajeev Ojha; Bikram Prasad Gajurel; Jonathan Quinonez; Samir Ruxmohan; Trevine Albert; Steven Licata; Joel Stien
Journal:  Neurol Int       Date:  2022-01-11

Review 3.  Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option.

Authors:  Michel Zimmermann; Christoph Oehler; Ulrich Mey; Pirus Ghadjar; Daniel Rudolf Zwahlen
Journal:  Radiat Oncol       Date:  2016-08-30       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.